Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Mosapride and Linagliptin on Incretin Hormones in T2DM
NCT02180334Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mosapride in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Started Jul 2014; status: completed.
02
Drugs
mosapride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02180334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180334.